Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Fall;10(Suppl 1):S37-S42.
doi: 10.15171/jlms.2019.S7. Epub 2019 Dec 1.

Laser Therapy for Peyronie's Disease: A Randomized Control Double-Blind Pilot Study

Farzad Allameh  1 , Mohammadreza Razzaghi  2 , Seyed Mansoor Rayegani  3 , Morteza Fallah-Karkan  2   4 , Arash Ranjbar  4 , Amirhosein Rahavian  4 , Atefeh Javadi  3 , Saleh Ghiasy  4 , Zahra Razzaghi  2
Affiliations

Laser Therapy for Peyronie's Disease: A Randomized Control Double-Blind Pilot Study

Farzad Allameh et al. J Lasers Med Sci. 2019 Fall.

Abstract

Introduction: The management of Peyronie's disease (PD) has remained a therapeutic dilemma for physicians and there is no gold standard treatment. In this paper, we decided to investigate the beneficial effect of the intralesional administration of verapamil compared with the intralesional administration of verapamil plus a low-intensity laser (LIL). Methods: Research was activated from May 2016 to May 2018 and a total of 38 men aged 18 years and older completed the investigation. The subjects were randomly divided into 2 groups. Group 1 was composed of 22 patients that were treated only by verapamil (5 mg) plus a sham laser weekly for 6 weeks, and group 2 consisted of 22 patients that received a laser, using the BTL-6000 HIGH-INTENSITY LASER 12 W machine and the same protocol of intralesional verapamil injection. The visual analogue scale (VAS) was used to evaluate pain during an erection, penile ultrasonography was used to measure plaque size, the penile curvature angle degree was measured using the photographs taken during an erection, and the International Index of Erectile Function questionnaire was used to assess erectile function. The follow-up treatment lasted for nine months, with visits performed in the 3rd and 9th months. Results: All study parameters decreased significantly after treatment in both arms, but the reduction in pain and penile curvature improvements in combination therapy revealed more significant changes in 3 months (p = .035, p=.032). Nevertheless, these improvements were not seen in the follow-up session after 9 months. Conclusion: A laser appears to be safe treatment modality in carefully-selected patients with PD. It has moderate efficacy in the short term.

Keywords: Erectile dysfunction; Intralesional injections; Laser therapy; Penile curvature; Peyronie’s disease; Verapamil.

PubMed Disclaimer

Figures

Figure 1
Figure 1
See this image and copyright information in PMC

References

    1. Mehrsai AR, Namdari F, Salavati A, Dehghani S, Allameh F, Pourmand G. Comparison of transdermal electromotive administration of verapamil and dexamethasone versus intra‐lesional injection for Peyronie’s disease. Andrology. 2013;1(1):129–32. doi: 10.1111/j.2047-2927.2012.00018.x. - DOI - PubMed
    1. Muñoz-Rangel CA, Fernandez-Vivar E, Bañuelos-Gallo RA, Gonzalez-Ojeda A, Macias-Amezcua MD, Chavez-Tostado M. et al. Minimally invasive therapy using intralesional onabotulinumtoxin A in Peyronie’s disease. Urol J. 2015;12(2):2105–10. doi: 10.22037/uj.v12i2.2894. - DOI - PubMed
    1. Pavone C, D’Amato F, Dispensa N, Torretta F, Magno C. Smoking, diabetes, blood hypertension: possible etiologic role for Peyronie’s disease? Analysis in 279 patients with a control group in Sicily. Arch Ital Urol Androl. 2015;87(1):20–4. doi: 10.4081/aiua.2015.1.20. - DOI - PubMed
    1. Moreland R, Nehra A. Pathophysiology of Peyronie’s disease. Int J Impot Res. 2002;14(5):406–10. doi: 10.1038/sj.ijir.3900875. - DOI - PubMed
    1. Tapscott AH, Hakim LS. Office-based management of impotence and Peyronie’s disease. Urol Clin North Am. 2013;40(4):521–43. doi: 10.1016/j.ucl.2013.07.003. - DOI - PubMed

LinkOut - more resources